-5%
Highnoon Labs
Genthro 500mg Tablets 6s
20 Tablets
Rated 4.5 out of 5 (49)
Rs. 1,275Rs. 1,340
In Stock
-15%
PharmEvo
Hilvel 400mg100mg Tablets 1s
Rated 4.5 out of 5 (32)SKU HP-09933
A tablet containing Sofosbuvir + Velpatasvir, indicated for Hepatitis.
Rs. 1,045Rs. 1,230-15%
You save Rs. 185
50g Cream
In StockSet your city for an exact delivery date
In stock at selected branches
Quantity
Hilvel 400mg100mg Tablets 1s quantity: 1
- 100% authentic
- Free over Rs. 1,500
- Pharmacist verified
- 7-day returns
Total for 1 pack: Rs. 1,045
What it is used for: Hepatitis.
Indications as listed by the manufacturer: Sofosbuvir + Velpatasvir is indicated for the treatment of adult patients with chronic hepatitis C virus (HCV) genotype 1, 2, 3, 4, 5 or 6: - Without cirrhosis or with compensated cirrhosis. - With decompensated cirrhosis for use in combination with ribavirin .
How it works: Sofosbuvir: Sofosbuvir is a pan-genotypic inhibitor of the HCV NS5B RNA-dependent RNA polymerase, which is essential for viral replication. Sofosbuvir is a nucleotide prodrug that undergoes intracellular metabolism to form the pharmacologically active uridine analog triphosphate (GS-461203), which can be incorporated into HCV RNA by the NS5B polymerase and acts as a chain terminator. Velpatasvir: Velpatasvir is a HCV inhibitor targeting the HCV NS5A protein, which is essential for both RNA replication and the assembly of HCV virions. Resistance selection in cell culture and cross-resistance studies indicate velpatasvir targets NS5A as its mode of action.
Active ingredient: Sofosbuvir + Velpatasvir.
Reported side effects: The most common adverse reactions (incidence greater than or equal to 10%, all grades) observed with treatment with sofosbuvir + velpatasvir for 12 weeks are headache, fatigue, nausea, nasopharyngitis, insomnia, diarrhea, asthenia, cough, back pain and arthralgia.
Known drug interactions: Antacids (e.g., aluminum and magnesium hydroxide) , H2 - receptor antagonists (e.g., famotidine) , Proton-pump inhibitors (e.g., omeprazole) , amiodarone , Digoxin , topotecan , carbamazepine , phenytoin , phenobarbital , oxcarbazepine , rifabutin rifampin , rifapentine , Efavirenz , Tipranavir / ritonavir , St. John’s wort (Hypericum perforatum) , rosuvastatin , atorvastatin.
- Sourced through authorised distributors and checked against batch and expiry on arrival
- Dispensed by a registered pharmacist from our DRAP-licensed branches
- Free pharmacist advice on interactions and timing — call or ask at checkout
- Same-day delivery in Karachi, Lahore and Islamabad on orders placed before 6pm
Adults : The recommended dosage of Sofosbuvir + Velpatasvir is one tablet taken orally once daily with or without food. Patients without cirrhosis and patients with compensated cirrhosis (Child-Pugh A) : Sofosbuvir + Velpatasvir 12 weeks Addition of ribavirin may be considered for genotype 3 infected patients with compensated cirrhosis. OR As directed by your physician.
Active ingredient: Sofosbuvir + Velpatasvir. Labelled strength: 400mg/100mg.
- Sofosbuvir + velpatasvir is contraindicated in patients with known hypersensitivity to sofosbuvir or to velpatasvir or to any excipient of the product. - Sofosbuvir + velpatasvir and ribavirin combination regimen is contraindicated in patients for whom ribavirin is contraindicated. - Sofosbuvir + velpatasvir should not be administered concurrently with other medicinal products containing any of the same active components.
- Test all patients for evidence of current or prior HBV infection by measuring HBsAg and anti-HBc before initiating HCV treatment with sofosbuvir + velpatasvir. In patients with serologic evidence of HBV infection, monitor for clinical and laboratory signs of hepatitis flare or HBV reactivation during HCV treatment with sofosbuvir + velpatasvir and during post-treatment follow-up. Initiate appropriate patient management for HBV infection as clinically indicated.
- If sofosbuvir + velpatasvir is administered with ribavirin, the warnings and precautions for ribavirin apply to this combination regimen.
- Direct acting anti-viral have been associated with hepatitis B virus (HBV) reactivation in patients who have a current or previous infection with HBV and are treated with certain Direct-Acting Antiviral (DAA) medicines for hepatitis C virus. Health Care Professionals should screen all patients for evidence of current or prior HBV infection before starting treatment with DAAs and monitor patients through blood tests for HBV flare-ups or reactivation during treatment and post-treatment follow-up .
- Serious symptomatic bradycardia may occur in patients taking amiodarone, particularly in patients also receiving beta blockers or those with underlying cardiac comorbidities and/or advanced liver disease. Co-administration of amiodarone with sofosbuvir + velpatasvir is not recommended. In patients without alternative viable treatment options, cardiac monitoring is recommended.
Store this medicine at room temperature, away from direct light and heat.
Manufactured by Hilvel Laboratories (Pvt) Ltd.. Country of origin: United Arab Emirates.
4.5
Rated 4.5 out of 532 verified ratings
- 5★83%
- 4★17%
- 3★0%
- 2★0%
- 1★0%
- Hina RazaVerified Purchase4 Aug 2026Rated 4.0 out of 5
Genuine product, sealed and well within expiry. Delivery reached Multan the next day.
- Nadia IqbalVerified Purchase26 Jul 2026Rated 5.0 out of 5
Second time ordering. Batch and expiry were printed clearly and matched what the site listed.
- Kamran AliVerified Purchase19 Jul 2026Rated 5.0 out of 5
Good value for the pack size. I compared prices across three sites before ordering.
- Imran Q.Verified Purchase3 Jul 2026Rated 5.0 out of 5
Exactly what my doctor prescribed. The pharmacist called to confirm the strength before dispatch, which I appreciated.
- Sana MalikVerified Purchase23 Jun 2026Rated 5.0 out of 5
Second time ordering. Batch and expiry were printed clearly and matched what the site listed.
- Shahid Hussain31 May 2026Rated 5.0 out of 5
Been using this for a few months now. Ordering here is cheaper than my local shop and the packing is always careful.
Reviews are from verified Hope Pharmacy orders. We do not remove a review for being critical.
What it is used for: Hepatitis.
Indications as listed by the manufacturer: Sofosbuvir + Velpatasvir is indicated for the treatment of adult patients with chronic hepatitis C virus (HCV) genotype 1, 2, 3, 4, 5 or 6: - Without cirrhosis or with compensated cirrhosis. - With decompensated cirrhosis for use in combination with ribavirin .
How it works: Sofosbuvir: Sofosbuvir is a pan-genotypic inhibitor of the HCV NS5B RNA-dependent RNA polymerase, which is essential for viral replication. Sofosbuvir is a nucleotide prodrug that undergoes intracellular metabolism to form the pharmacologically active uridine analog triphosphate (GS-461203), which can be incorporated into HCV RNA by the NS5B polymerase and acts as a chain terminator. Velpatasvir: Velpatasvir is a HCV inhibitor targeting the HCV NS5A protein, which is essential for both RNA replication and the assembly of HCV virions. Resistance selection in cell culture and cross-resistance studies indicate velpatasvir targets NS5A as its mode of action.
Active ingredient: Sofosbuvir + Velpatasvir.
Reported side effects: The most common adverse reactions (incidence greater than or equal to 10%, all grades) observed with treatment with sofosbuvir + velpatasvir for 12 weeks are headache, fatigue, nausea, nasopharyngitis, insomnia, diarrhea, asthenia, cough, back pain and arthralgia.
Known drug interactions: Antacids (e.g., aluminum and magnesium hydroxide) , H2 - receptor antagonists (e.g., famotidine) , Proton-pump inhibitors (e.g., omeprazole) , amiodarone , Digoxin , topotecan , carbamazepine , phenytoin , phenobarbital , oxcarbazepine , rifabutin rifampin , rifapentine , Efavirenz , Tipranavir / ritonavir , St. John’s wort (Hypericum perforatum) , rosuvastatin , atorvastatin.
- Sourced through authorised distributors and checked against batch and expiry on arrival
- Dispensed by a registered pharmacist from our DRAP-licensed branches
- Free pharmacist advice on interactions and timing — call or ask at checkout
- Same-day delivery in Karachi, Lahore and Islamabad on orders placed before 6pm
Adults : The recommended dosage of Sofosbuvir + Velpatasvir is one tablet taken orally once daily with or without food. Patients without cirrhosis and patients with compensated cirrhosis (Child-Pugh A) : Sofosbuvir + Velpatasvir 12 weeks Addition of ribavirin may be considered for genotype 3 infected patients with compensated cirrhosis. OR As directed by your physician.
Active ingredient: Sofosbuvir + Velpatasvir. Labelled strength: 400mg/100mg.
- Sofosbuvir + velpatasvir is contraindicated in patients with known hypersensitivity to sofosbuvir or to velpatasvir or to any excipient of the product. - Sofosbuvir + velpatasvir and ribavirin combination regimen is contraindicated in patients for whom ribavirin is contraindicated. - Sofosbuvir + velpatasvir should not be administered concurrently with other medicinal products containing any of the same active components.
- Test all patients for evidence of current or prior HBV infection by measuring HBsAg and anti-HBc before initiating HCV treatment with sofosbuvir + velpatasvir. In patients with serologic evidence of HBV infection, monitor for clinical and laboratory signs of hepatitis flare or HBV reactivation during HCV treatment with sofosbuvir + velpatasvir and during post-treatment follow-up. Initiate appropriate patient management for HBV infection as clinically indicated.
- If sofosbuvir + velpatasvir is administered with ribavirin, the warnings and precautions for ribavirin apply to this combination regimen.
- Direct acting anti-viral have been associated with hepatitis B virus (HBV) reactivation in patients who have a current or previous infection with HBV and are treated with certain Direct-Acting Antiviral (DAA) medicines for hepatitis C virus. Health Care Professionals should screen all patients for evidence of current or prior HBV infection before starting treatment with DAAs and monitor patients through blood tests for HBV flare-ups or reactivation during treatment and post-treatment follow-up .
- Serious symptomatic bradycardia may occur in patients taking amiodarone, particularly in patients also receiving beta blockers or those with underlying cardiac comorbidities and/or advanced liver disease. Co-administration of amiodarone with sofosbuvir + velpatasvir is not recommended. In patients without alternative viable treatment options, cardiac monitoring is recommended.
Store this medicine at room temperature, away from direct light and heat.
Manufactured by Hilvel Laboratories (Pvt) Ltd.. Country of origin: United Arab Emirates.
4.5
Rated 4.5 out of 532 verified ratings
- 5★83%
- 4★17%
- 3★0%
- 2★0%
- 1★0%
- Hina RazaVerified Purchase4 Aug 2026Rated 4.0 out of 5
Genuine product, sealed and well within expiry. Delivery reached Multan the next day.
- Nadia IqbalVerified Purchase26 Jul 2026Rated 5.0 out of 5
Second time ordering. Batch and expiry were printed clearly and matched what the site listed.
- Kamran AliVerified Purchase19 Jul 2026Rated 5.0 out of 5
Good value for the pack size. I compared prices across three sites before ordering.
- Imran Q.Verified Purchase3 Jul 2026Rated 5.0 out of 5
Exactly what my doctor prescribed. The pharmacist called to confirm the strength before dispatch, which I appreciated.
- Sana MalikVerified Purchase23 Jun 2026Rated 5.0 out of 5
Second time ordering. Batch and expiry were printed clearly and matched what the site listed.
- Shahid Hussain31 May 2026Rated 5.0 out of 5
Been using this for a few months now. Ordering here is cheaper than my local shop and the packing is always careful.
Reviews are from verified Hope Pharmacy orders. We do not remove a review for being critical.
Frequently bought together
PharmEvoHilvel 400mg100mg Tablets 1sRs. 1,045Rated 4.5 out of 5
StandpharmXiga 5mg Tablets 14sRs. 1,595Rated 4.5 out of 5
Martin DowAldactone Tablets 100mg 10sRs. 1,390Rated 4.5 out of 5
Bundle total
Rs. 4,030Rs. 4,460
Information on this site is for general guidance and is not a substitute for professional medical advice. Always consult your doctor or pharmacist.
You might also like
More in Medicine
